Abstract
Electromagnetic compatibility (EMC) in biomedical applications is a significant issue related to the user’s life safety, especially in implantable medical devices. Cardiovascular diseases and neurodegenerative disorders are the main chronic disease worldwide that rely on implantable treatment devices such as cardiac pacemakers and vagus nerve stimulators. Both devices must have high EMC to avoid electromagnetic interference-induced health risks, even death during the treatment. Thus, it is important to understand how EMI can affect implantable devices and proactively protect devices from electromagnetic interference, providing reliable and safe implantable device therapy. To this end, this chapter comprehensively introduces the clinical issues and provides EMC requirements for the implantable device such as a cardiac pacemaker and vagus nerve stimulator. The significance of this chapter is to present the EMC important issues in medical engineering that can help to evolve reliable and secure implantable device development in the future.
Highlights
The cardiac pacemaker would be activated once the heart detector measures the abnormal cardiac rhythm
Cardiovascular diseases (CVDs) are the major cause of death globally, which takes an estimated 17.9 million lives per year based on the World Health Organization (WHO) statistics
electromagnetic interference (EMI) is due to radiation that can be through the air from many possible sources (Table 1) in our daily life [17–20], including the
Summary
Cardiovascular diseases (CVDs) are the major cause of death globally, which takes an estimated 17.9 million lives per year based on the World Health Organization (WHO) statistics. Arrhythmia has a strong clinical correlation with sudden cardiac death (SCD) [1]. The irregular heart rhythm called arrhythmia can mainly be divided into two main types: tachycardia arrhythmia and bradycardia arrhythmia. The tachycardia and bradycardia arrhythmia represent the heart beats too fast and slow, respectively. The physical treatment for tachycardia and bradycardia syndrome required a regulator to suppress the abnormal heart rhythm. The implantable cardiac pacemaker is commonly applied in the cardiac modulation that generates the electrical stimulation pulse to regulate the heart’s sinoatrial node, obtaining the normal rhythm. The cardiac pacemaker would be activated once the heart detector measures the abnormal cardiac rhythm. The stable operation of a cardiac pacemaker is important for adverse patients, providing prompt treatment in arrhythmia
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have